Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0089-2023Class II

Dimension Vista High Density Lipoprotein Cholesterol (HDLC) Flex reagent cartridge, IVD Siemens Material...

Siemens Healthcare Diagnostics Inc. / initiated 2022-08-24 / Open, Classified

Siemens Healthcare Diagnostics, Inc. began a recall of Dimension Vista High Density Lipoprotein Cholesterol (HDLC) Flex reagent cartridge, IVD Siemens Material Number (SMN): 10464340 Catalog Number: K3048A on . FDA classified it as Class II and gives the reason as "Dimension Vista High Density Lipoprotein Cholesterol (HDLC) Potential for Erroneous Result. If an HDLC QC or patient result is obtained without an Abnormal Reaction [E145]: flag, a falsely depressed or elevated result...". As of , the recall status on record is Open, Classified.

Recall record

Recall number
Z-0089-2023
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Siemens Healthcare Diagnostics Inc.
Product
Dimension Vista High Density Lipoprotein Cholesterol (HDLC) Flex reagent cartridge, IVD Siemens Material Number (SMN): 10464340 Catalog Number: K3048A
Product code
JHM Colorimetric Method, Lipoproteins
Reason for recall
Dimension Vista High Density Lipoprotein Cholesterol (HDLC) Potential for Erroneous Result. If an HDLC QC or patient result is obtained without an Abnormal Reaction [E145]: flag, a falsely depressed or elevated result ranging from -90% to 133% may be observed.
FDA root cause
Under Investigation by firm
Action
Siemens issued an Urgent Medical Device Correction (UMDC) mailed to US affected customers by FedEx beginning on 08/24/2022. An Urgent Field Safety Notice (UFSN) was issued to all OUS Siemens reporting sites with affected customers, for distribution and regional reporting to their local competent authorities beginning on 08/24/2022. Letter states: Discontinue use of and discard the lot listed in Table 1. Review your inventory of this lot to determine your laboratory s replacement needs and to provide information to Siemens for reporting to the Authorities. Please review this letter with your Medical Director. Complete and return the Field Correction Effectiveness Check Form attached to this letter within 30 days to Siemens Healthineers for reporting to the Authorities. If you have received any complaints of illness or adverse events associated with the products listed in Table 1, immediately contact your local Siemens Healthineers Customer Care Center or your local Siemens Healthineers Technical Support Representative. Please retain this letter with your laboratory records and forward this letter to those who may have received this product. If you have any questions, please contact your Siemens Healthineers Customer Care Center or your local Siemens Healthineers Technical Support Representative.
Quantity in commerce
1592 units
Distribution
Nationwide Foreign: Canada
Product codes and lots
UDI-DI : 0084276802043821250BA2022090710464340840 Lot Number: 21250BA Exp. Date: 2022-09-07

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0089-2023
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0089-2023Class IIOngoingVoluntary: Firm initiated